Shionogi (paid to University of Edinburgh)
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Shionogi (paid to University of Edinburgh); Enthorin Therapeutics (paid to University of Edinburgh)
Zynerba Pharmaceuticals - Clinical Trial Grant for "A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Fragile X Syndrome – RECONNECT"
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Shionogi (paid to University of Edinburgh)
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Roche (paid to University of Edinburgh)
Roche - Clinical Trial Grant paid to NHS Lothian for "A Phase III, Randomised, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study Of Balovaptan In Adults With Autism Spectrum Disorder with a 2-year Open-Label Extension"
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Novartis (paid to University of Edinburgh)
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Novartis (paid to University of Edinburgh)
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Roche - Clinical Trial Grant paid to NHS Lothian and University of Edinburgh for “A randomized, double-blind, 12- week, parallel group, placebo controlled study of the efficacy and safety of RO4917523 in patients with Fragile X Syndrome”
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.
Roche (paid to University of Edinburgh)
Novartis - Clinical Trial grant paid to NHS Lothian for “A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate AFQ056 in Adult Patients With Fragile X Syndrome” plus the 2 year follow-up open label study; and “A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate AFQ056 in Adolescent Patients With Fragile X Syndrome” plus the 2 year follow-up open label study.
Something wrong with this declaration? Contact team@sunshineuk.org to let them know.